Asian Paints

2953.5 -0.90

Cipla

1508 -8.60

Eicher Motors

7081.5 -31.00

Nestle India

1241.9 -17.00

Grasim Inds

2720.3 -14.70

Hindalco Inds.

816.3 9.45

Hind. Unilever

2448 -29.80

ITC

400.5 -0.45

Trent

4188.2 -38.30

Larsen & Toubro

3988 -42.50

M & M

3649.4 -67.10

Reliance Industr

1538.8 -7.50

Tata Consumer

1140 -22.20

Tata Motors PVeh

356.85 -4.90

Tata Steel

166.92 -0.86

Wipro

254.69 4.52

Apollo Hospitals

7184 -58.00

Dr Reddy's Labs

1280.7 5.50

Titan Company

3817.8 -68.00

SBI

951.05 -16.25

Shriram Finance

828.1 -15.30

Bharat Electron

403.95 -9.10

Kotak Mah. Bank

2146.1 3.70

Infosys

1578.7 17.70

Bajaj Finance

1021.4 -4.10

Adani Enterp.

2189.8 -49.80

Sun Pharma.Inds.

1806.7 7.20

JSW Steel

1143.6 -18.40

HDFC Bank

1000.5 10.70

TCS

3180 44.30

ICICI Bank

1391.5 18.50

Power Grid Corpn

268.45 1.00

Maruti Suzuki

16082 -157.00

Axis Bank

1270.7 12.70

HCL Technologies

1640.5 5.00

O N G C

240.02 -3.52

NTPC

322.95 -5.65

Coal India

375.25 -3.70

Bharti Airtel

2086 -18.00

Tech Mahindra

1541.7 5.00

Jio Financial

301 -3.85

Adani Ports

1497.7 -20.40

HDFC Life Insur.

751.95 -7.05

SBI Life Insuran

1972.8 -8.70

Max Healthcare

1086 -31.50

UltraTech Cem.

11591 -75.00

Bajaj Auto

9000.5 -85.00

Bajaj Finserv

2046 -19.90

Interglobe Aviat

5595.5 -102.00

Eternal Ltd

297.75 -2.80

IPO-Synopsis
Nephrocare Health Services Ltd
  • Registered Office: 5th Flr D Block iLabs Centre,Plot 18 Software Units Sy.#.64, Hyderabad - 500081, Telangana, India. Phone : +91 40 4240 8039   Fax:
  • Email : cs@nephroplus.com
  • Website :www.nephroplus.com
Initial public offering of up to [*] equity shares of face value of Rs.2/- each ("Equity Shares") of Nephrocare Health Services Limited ("the Company" or the "Company" or the "Issuer") for cash at a price of Rs.[*] per equity share face value of Rs.2/- (Including a Securities Premium of Rs.[*] per Equity Share) ("Offer Price") aggregating up to Rs.[*] crores ("Offer") comprising a fresh issue of [*] equity shares of face value of Rs.2/- each aggregating up to Rs.353.41 crores ("Fresh Issue") and an offer for sale of up to 12,792,056 equity shares of face value of Rs.2/- each ("Offered Shares") aggregating up to Rs.[*] crores, comprising an offer for sale of up to 1,660,360 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Investcorp Private Equity Fund ii and up to 1,813,140 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Healthcare Parent Limited and up to 147,765 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Investcorp Growth Opportunity Fund and up to 4,081,000 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Edoras Investment Holdings Pte. Ltd. ("Promoter Selling Shareholders") and up to 121,985 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by Investcorp India Private Equity Opportunity Limited and up to 3,089,663 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by International Finance Coproration and up to 1,433,468 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by 360 One Special Opportunities Fund - Series 9 and up to 444,675 equity shares of face value of Rs.2/- each aggregating up to Rs.[*] crores by 360 One Special Opportunities Fund - Series 10 ("Other Selling Shareholders" and together with the promoter selling shareholders, the "Selling Shareholders" and such offer for sale by the selling shareholders, the "Offer for Sale"). The offer shall constitute [*]% of the post-offer paid-up equity share capital of the company. The offer includes a reservation of up to [*] equity shares of face value of Rs.2/- each, aggregating up to Rs.[*] crores (Constituting up to [*]% of the post-offer paid-up Equity Share Capital), for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as the "Net Offer". the offer and the net offer shall constitute [*]% and [*]% of the post-offer paid-up equity share capital of the company, respectively. The company, may in consultation with the brlms, offer a discount of Rs.[*] on the issue price to eligible employees bidding in the employee reservation portion ("Employee Discount"). The face value of the equity shares is Rs.2/- each. The offer price is [*] times the face value of the equity shares. The price band and the minimum bid lot will be decided by the company.
Issue
Opens On Closes On
10-Dec-25 12-Dec-25
Money Payable On
Application Allotment
0.00 0.00
Minimum Application for shares in Nos : 0 Further Multiples of : 0
Cr Lead Managers to the Issue
Project Cost (.Cr) 0.00 Ambit Private Limited
Project Financed through Current Offer (.Cr) 0.00  
Post Issue Equity Share Capital (.Cr) 0.00
Issue Price () 0.00
Projects
Capital expenditure by our Company for opening new dialysis clinics in India
Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by our Company
General corporate purposes
Promoted By
Vikram Vuppala
Bessemer Venture Partners Trus
Edoras Investment Holdings Pte
Listing At
BSE
NSE
Registrar to the Issue
No Data Available

DJIA 47501.07
190.74 0.40%
S&P 500 6850.51
16.88 0.25%
HANG SENG 25760.74
-334.32 -1.28%
NIKKEI 225 49986.70
683.25 1.39%
FTSE 100 9706.66
4.13 0.04%
NIFTY 25986.00
-46.20 -0.18%
×
Ask Your Question
close
refresh